Introduction: The oldest-old population (80 years or older) has the highest lethality from COVID-19. There is little information on the clinical presentation and specific prognostic factors for this group. This trial evaluated the clinical presentation and prognostic factors of severe disease and mortality in the oldest-old population. Methods: This is an ambispective cohort study of oldest-old patients hospitalized for respiratory infection associated with COVID-19 and with a positive test by RT-PCR. The clinical presentation and the factors associated with severe disease and mortality were evaluated (logistic regression). All patients were followed up until discharge or death. Results: A total of 103 patients (59.2% female) were included. The most frequent symptoms were fever (68.9%), dyspnoea (60.2%), and cough (39.8%), and 11.7% presented confusion. Fifty-nine patients (57.3%) presented severe disease, and 59 died, with 43 patients (41.7%) presenting both of these. In the multivariate analysis, female sex (odds ratio [OR] 0.31, 95% confidence interval [95% CI] 0.13–0.73, p 0.0074) and serum lactate dehydrogenase (LDH) (OR 2.55, 95% CI 1.21–5.37, p 0.0139) were associated with severe disease, and serum sodium was associated with mortality (OR 3.12, 95% CI 1.18–8.26, p 0.0222). No chronic disease or pharmacological treatment was associated with worse outcomes. Conclusions: The typical presenting symptoms of respiratory infection in COVID-19 are less frequent in the oldest-old population. Male sex and LDH level are associated with severe disease, and the serum sodium level is associated with mortality in this population.

1.
Guo
Y
,
Liu
X
,
Deng
M
,
Liu
P
,
Li
F
,
Xie
N
,
Epidemiology of COVID-19 in older persons, Wuhan, China
.
Age Ageing
.
2020 Aug 24
;
49
(
5
):
706
12
.
2.
Bonanad
C
,
García-Blas
S
,
Tarazona-Santabalbina
F
,
Sanchis
J
,
Bertomeu-González
V
,
Fácila
L
,
The effect of age on mortality in patients with COVID-19: a meta-analysis with 611,583 subjects
.
J Am Med Dir Assoc
.
2020 Jul
;
21
(
7
):
915
18
.
3.
High
KP
,
Bradley
SF
,
Gravenstein
S
,
Mehr
DR
,
Quagliarello
VJ
,
Richards
C
,
Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities: 2008 update by the Infectious Diseases Society of America
.
J Am Geriatr Soc
.
2009 Jan 15
;
48
(
2
):
149
71
.
4.
Samaras
N
,
Chevalley
T
,
Samaras
D
,
Gold
G
.
Older patients in the emergency department: a review
.
Ann Emerg Med
.
2010 Sep
;
56
(
3
):
261
9
.
5.
Norman
DC
,
Yoshikawa
TT
.
Fever in the elderly
.
Infect Dis Clin North Am
.
1996 Mar
;
10
(
1
):
93
9
.
6.
Lithander
FE
,
Neumann
S
,
Tenison
E
,
Lloyd
K
,
Welsh
TJ
,
Rodrigues
JCL
,
COVID-19 in older people: a rapid clinical review
.
Age Ageing
.
2020 Jul
;
49
(
4
):
501
15
.
7.
Le Quintrec
JL
,
Bussy
C
,
Golmard
JL
,
Hervé
C
,
Baulon
A
,
Piette
F
.
Randomized controlled drug trials on very elderly subjects: descriptive and methodological analysis of trials published between 1990 and 2002 and comparison with trials on adults
.
J Gerontol A Biol Sci Med Sci
.
2005
;
60
(
3
):
340
4
. .
8.
Shenoy
P
,
Harugeri
A
.
Elderly patients’ participation in clinical trials
.
Perspect Clin Res
.
2015
;
6
(
4
):
184
9
. .
9.
Ramos-Rincon
J-M
,
Buonaiuto
V
,
Ricci
M
,
Martín-Carmona
J
,
Paredes-Ruíz
D
,
Calderón-Moreno
M
,
Clinical characteristics and risk factors for mortality in very old patients hospitalized with COVID-19 in Spain
.
J Gerontol A Biol Sci Med Sci
.
2021 Feb 25
;
76
(
3
):
e28
37
.
10.
Covino
M
,
De Matteis
G
,
Santoro
M
,
Sabia
L
,
Simeoni
B
,
Candelli
M
,
Clinical characteristics and prognostic factors in COVID-19 patients aged ≥80 years
.
Geriatr Gerontol Int
.
2020
;
20
(
7
):
704
8
. .
11.
Gutiérrez Rodríguez
J
,
Montero Muñoz
J
,
Jiménez Muela
F
,
Guirola García-Prendes
C
,
Martínez Rivera
M
,
Gómez Armas
L
.
Variables associated with mortality in a selected sample of patients older than 80 years and with some degree of functional dependence hospitalized for COVID-19 in a Geriatrics Service
.
Rev Esp Geriatr Gerontol
.
2020 Nov–Dec
;
55
(
6
):
317
25
.
12.
Rodríguez-Molinero
A
,
Gálvez-Barrón
C
,
Miñarro
A
,
Macho
O
,
López
GF
,
Robles
MT
,
Association between COVID-19 prognosis and disease presentation, comorbidities and chronic treatment of hospitalized patients
.
PLoS One
.
2020 Oct 15
;
15
(
10
):
e0239571
. .
13.
Berlin
DA
,
Gulick
RM
,
Martinez
FJ
.
Severe Covid-19
.
N Engl J Med
.
2020
;
383
(
25
):
2451
60
. .
14.
WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection
.
A minimal common outcome measure set for COVID-19 clinical research
.
Lancet Infect Dis
.
2020
;
20
:
e192
7
.
15.
Benjamini
Y
,
Hochberg
Y
.
Controlling the false discovery rate: a practical and powerful approach to multiple testing
.
J Roy Statist Soc Ser B
.
1995
;
57
(
1
):
289
300
. .
16.
Tibshirani
R
.
Regression shrinkage and selection via the Lasso
.
J Roy Statist Soc Ser B
.
1996
;
58
(
1
):
267
88
. .
17.
Núñez
E
,
Steyerberg
EW
,
Núñez
J
.
[Regression modeling strategies]
.
Rev Esp Cardiol
.
2011
;
64
(
6
):
501
7
. .
18.
Argenziano
MG
,
Bruce
SL
,
Slater
CL
,
Tiao
JR
,
Baldwin
MR
,
Barr
RG
,
Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series
.
BMJ
.
2020 May 29
;
369
:
m1996
. .
19.
Liang
WH
,
Guan
WJ
,
Li
CC
,
Li
YM
,
Liang
HR
,
Zhao
Y
,
Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China
.
Eur Respir J
.
2020
;
55
(
6
):
2000562
. .
20.
Jiménez
E
,
Fontán-Vela
M
,
Valencia
J
,
Fernandez-Jimenez
I
,
Álvaro-Alonso
EA
,
Izquierdo-García
E
,
Characteristics, complications and outcomes among 1549 patients hospitalised with COVID-19 in a secondary hospital in Madrid, Spain: a retrospective case series study
.
BMJ Open
.
2020
;
10
(
11
):
e042398
. .
21.
Annweiler
C
,
Sacco
G
,
Salles
N
,
Aquino
J-P
,
Gautier
J
,
Berrut
G
,
National French survey of COVID-19 symptoms in people aged 70 and over
.
Clin Infect Dis
.
2021 Feb 1
;
72
(
3
):
490
4
.
22.
Zhao
H-L
,
Huang
Y-M
,
Huang
Y
.
Mortality in older patients with COVID-19
.
J Am Geriatr Soc
.
2020 Aug
;
68
(
8
):
1685
7
.
23.
Shahid
Z
,
Kalayanamitra
R
,
McClafferty
B
,
Kepko
D
,
Ramgobin
D
,
Patel
R
,
COVID-19 and older adults: what we know
.
J Am Geriatr Soc
.
2020
;
68
(
5
):
926
9
. .
24.
Mostaza
JM
,
García-Iglesias
F
,
González-Alegre
T
,
Blanco
F
,
Varas
M
,
Hernández-Blanco
C
,
Clinical course and prognostic factors of COVID-19 infection in an elderly hospitalized population
.
Arch Gerontol Geriatr
.
2020 Jul 27
;
91
:
104204
.
25.
Izcovich
A
,
Ragusa
MA
,
Tortosa
F
,
Lavena Marzio
MA
,
Agnoletti
C
,
Bengolea
A
,
Prognostic factors for severity and mortality in patients infected with COVID-19: a systematic review
.
PLoS One
.
2020
;
15
(
11
):
e0241955
. .
26.
Malik
P
,
Patel
U
,
Mehta
D
,
Patel
N
,
Kelkar
R
,
Akrmah
M
,
Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis
.
BMJ Evid Based Med
.
2020 Sep 15
. Epub ahead of print.
27.
Henry
BM
,
de Oliveira
MHS
,
Benoit
S
,
Plebani
M
,
Lippi
G
.
Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
.
Clin Chem Lab Med
.
2020 Jun 25
;
58
(
7
):
1021
8
. .
28.
Zhang
JJY
,
Lee
KS
,
Ang
LW
,
Leo
YS
,
Young
BE
.
Risk factors of severe disease and efficacy of treatment in patients infected with COVID-19: a systematic review, meta-analysis and meta-regression analysis
.
Clin Infect Dis
.
2020 Nov 19
;
71
(
16
):
2199
206
.
29.
Ou
M
,
Zhu
J
,
Ji
P
,
Li
H
,
Zhong
Z
,
Li
B
,
Risk factors of severe cases with COVID-19: a meta-analysis
.
Epidemiol Infect
.
2020 Aug 12
;
148
:
e175
.
30.
Han
Y
,
Zhang
H
,
Mu
S
,
Wei
W
,
Jin
C
,
Tong
C
,
Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study
.
Aging
.
2020 Jun 24
;
12
(
12
):
11245
58
.
31.
Kuang
ZS
,
Yang
YL
,
Wei
W
,
Wang
JL
,
Long
XY
,
Li
KY
,
Clinical characteristics and prognosis of community-acquired pneumonia in autoimmune disease-induced immunocompromised host: a retrospective observational study
.
World J Emerg Med
.
2020
;
11
(
3
):
145
51
. .
32.
Ding
J
,
Karp
JE
,
Emadi
A
.
Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: interplay between hematologic and solid neoplastic clones and their microenvironments
.
Cancer Biomark
.
2017
;
19
(
4
):
353
63
. .
33.
Gupta
A
,
Madhavan
MV
,
Sehgal
K
,
Nair
N
,
Mahajan
S
,
Sehrawat
TS
,
Extrapulmonary manifestations of COVID-19
.
Nat Med
.
2020
;
26
(
7
):
1017
32
. .
34.
Berry
SD
,
Ngo
L
,
Samelson
EJ
,
Kiel
DP
.
Competing risk of death: an important consideration in studies of older adults
.
J Am Geriatr Soc
.
2010
;
58
(
4
):
783
7
. .
35.
Zerah
L
,
Baudouin
É
,
Pépin
M
,
Mary
M
,
Krypciak
S
,
Bianco
C
,
Clinical characteristics and outcomes of 821 older patients with SARS-Cov-2 infection admitted to acute care geriatric wards
.
J Gerontol A Biol Sci Med Sci
.
2021 Feb 25
;
76
(
3
):
e4
12
.
36.
Working group for the surveillance and control of COVID-19 in Spain
.
The first wave of the COVID-19 pandemic in Spain: characterisation of cases and risk factors for severe outcomes, as at 27 April 2020
.
Euro Surveill
.
2020 Dec
;
25
(
50
):
2001431
.
37.
De Smet
R
,
Mellaerts
B
,
Vandewinckele
H
,
Lybeert
P
,
Frans
E
,
Ombelet
S
,
Frailty and mortality in hospitalized older adults with COVID-19: retrospective observational study
.
J Am Med Dir Assoc
.
2020 Jul
;
21
(
7
):
928
32.e1
. .
38.
Gálvez-Barrón
C
,
Arroyo-Huidobro
M
,
Miñarro
A
,
Añaños
G
,
Chamero
A
,
Martín
M
,
COVID 19: clinical presentation and prognostic factors of severe disease and mortality in the oldest-old population. A cohort study
. [Preprint].
2021 Jan 21
[cited 2021 Jan 22]. Available from: https://www.researchsquare.com/article/rs-104338/v3.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.